Vir Biotechnology Inc. VIR
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Vir Biotechnology Inc. is a clinical-stage biopharmaceutical company that discovers, develops, and advances immune-based therapies to treat and prevent serious infectious diseases and cancer. The company leverages its next-generation antibody platform and PRO-XTEN protease-releasable masking technology to power the imm…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees367
TickerVIR
Statistics
Market Cap$1.50B
Revenue (TTM)$68.6M
Net Income-$438.0M
Net Margin-638.9%
EPS$-3.16
P/E-2.69
P/S21.24
P/B1.50
EV/EBITDA-2.34
ROE-47.7%
Dividend Yield—
Price$9.30
Data: Twelve Data · Revenue = mcap / P/S